At this moment in time, and after consultation of the competent authorities, we do not foresee any interruptions in production and therefore no supply shortages for our medicinal products because of the coronavirus COVID-19.

We support this by a prevention program and our purchasing and production strategy:

• medac has prepared itself carefully to protect employees and supply chain,
• medac operates its own production sites in Central Europe and the goods transport within Europe is not limited up to now,
• generally, medac has more than one supplier for the intermediate products used for its medicinal products,
• medac has sufficient stocks of all intermediate products so that supply fluctuations will not cause immediate shortages.